✦ LIBER ✦

A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: A gynecologic oncology group study

✍ Scribed by Brigitte E. Miller; John A. Blessing; Frederick B. Stehman; Mark S. Shahin; S. Diane Yamada; Angeles Alvarez Secord; David P. Warshal; Ovadia Abulafia; William E. Richards; Linda Van Le

Book ID: 113962464
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 239 KB
Volume: 118
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2010.03.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II evaluation of topotecan in carc

Phase II evaluation of topotecan in carcinosarcoma of the uterus: A Gynecologic Oncology Group study

✍ David Scott Miller; John A. Blessing; Jeanne Schilder; Adnan Munkarah; Yi Chun L 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 91 KB

A phase II evaluation of pazopanib in th

A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group study

✍ Campos, Susana M.; Brady, William E.; Moxley, Katherine M.; O'Cearbhaill, Roisin 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 258 KB

A phase II evaluation of weekly docetaxe

A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: A study by the Gynecologic Oncology Group

✍ Agustin A. Garcia; John A. Blessing; Susan Nolte; Robert S. Mannel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Phase II trial of gemcitabine as second-

Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study

✍ Katherine Y Look; Alan Sandler; John A Blessing; Joseph A Lucci III; Peter G Ros 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB

A Phase II evaluation of weekly topoteca

A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: A Gynecologic Oncology Group study

✍ James V. Fiorica; John A. Blessing; Louis V. Puneky; Angeles Alvarez Secord; Jam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 142 KB

A phase II evaluation of flavopiridol as

A phase II evaluation of flavopiridol as second-line chemotherapy of endometrial carcinoma: A Gynecologic Oncology Group study

✍ Edward C. Grendys Jr.; John A. Blessing; Robert Burger; James Hoffman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 92 KB